Related Experiment Video
Updated: May 30, 2026

09:46
Training Persons with Spinal Cord Injury to Ambulate Using a Powered Exoskeleton
Published on: June 16, 2016
Consumer preference in ranking walking function utilizing the walking index for spinal cord injury II
M Patrick1, P Ditunno, J F Ditunno
1Thomas Jefferson University, Regional SCI Center of the Delaware Valley, Department of Rehabilitation Medicine, Philadelphia, PA 19107, USA. Mary.Patrick@jefferson.edu
Spinal Cord
|July 27, 2011
Summary
Consumers with spinal cord injury (SCI) surprisingly preferred walking with assistance over independent walking. This finding challenges assumptions and highlights the need to consider patient preferences in SCI clinical trial design.
Area of Science:
- Rehabilitation Medicine
- Clinical Trials
- Patient-Reported Outcomes
Background:
- Assessing walking function is crucial in spinal cord injury (SCI) rehabilitation.
- The Walking Index for SCI II (WISCI II) is a common scale for evaluating walking ability.
- Understanding patient preferences for different walking methods is essential for effective trial design.
Purpose of the Study:
- To determine consumer preferences for walking function using the WISCI II scale in individuals with SCI.
- To compare consumer preferences with objective measures in SCI walking function studies.
Main Methods:
- A blinded rank ordering method was employed.
- 42 individuals with incomplete SCI from Canada, Italy, and the USA participated.
- Participants ranked 20 levels of the WISCI II scale based on their walking preference, using percentile, conjoint/cluster, and graphic analyses.
Main Results:
- Consumer rankings of walking function exhibited a bimodal distribution.
- A significant preference for walking with assistance (e.g., walker, one person) was observed in a larger subgroup.
- Unexpectedly, 64% of consumers ranked levels involving assistance higher than levels requiring no assistance.
Conclusions:
- Consumer preferences for walking function diverge from traditional objective measures.
- Incorporating patient-reported outcomes and preferences is vital for designing meaningful SCI clinical trials.
- Future SCI trials should consider consumer preferences alongside objective walking function assessments.

